Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03553849
Recruitment Status : Recruiting
First Posted : June 12, 2018
Last Update Posted : July 15, 2019
Sponsor:
Information provided by (Responsible Party):
Christiana Care Health Services

Brief Summary:
The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and 30-day complications. Additionally, the investigators anticipate reduced perioperative blood glucose levels and a reduced need for perioperative insulin administration.

Condition or disease Intervention/treatment Phase
Morbid Obesity Dietary Supplement: Very low calorie diet Not Applicable

Detailed Description:

The investigators' objective for this project is to determine the impact of a preoperative VLCD on outcomes for patients undergoing elective general surgery. Included are patients who are obese, BMI >30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery. Eligible patients are those scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

The investigators will also be determining the feasibility of introducing a preoperative VLCD for patients undergoing elective general surgery in a Community Hospital setting.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The patient will be randomized into the treatment or control arm by the research team. If they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery.
Masking: Double (Care Provider, Outcomes Assessor)
Masking Description: The operative surgeons will be blinded to the randomization. The patient, by nature of the study, will not be blinded.
Primary Purpose: Prevention
Official Title: Utilization of Very Low Calorie Diet in Obese General Surgery Patients
Actual Study Start Date : September 24, 2018
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : August 1, 2020

Arm Intervention/treatment
Experimental: Very Low Calorie Diet
If they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery. Patients will be required to pay for the meal replacements.
Dietary Supplement: Very low calorie diet
The VLCD is a prescribed diet with well-balanced macro and micronutrients. It is intended for significant weight loss in a short period of time, is intended only for the extremely obese, and must be completed under the supervision of a trained physician.

No Intervention: Standard Preop Diet
The control group will continue a regular diet until the day before surgery.



Primary Outcome Measures :
  1. Reduction in Post Operative Complications [ Time Frame: 30-days post operatively ]
    Pulmonary, cardiac and surgical complications using data collected from inpatient and outpatient charting


Secondary Outcome Measures :
  1. Feasibility of the Study [ Time Frame: 2 weeks ]
    Patient satisfaction and compliance based on patient surveys administered prior to discharge from the hospital

  2. Effect on Perioperative BMI [ Time Frame: 2 weeks ]
    Difference in pre operative and perioperative BMI, in kg/m^2

  3. Effect on blood glucose levels [ Time Frame: 2 weeks ]
    Difference in pre operative and perioperative blood glucose levels

  4. Effect on insulin administration [ Time Frame: 2 weeks ]
    Difference in pre operative and perioperative insulin administration, in units

  5. Effect on operative times [ Time Frame: Day of surgery ]
    Comparative operative times, in minutes, between control and intervention

  6. Effect on operative blood loss [ Time Frame: Day of surgery ]
    Comparative operative blood loss, in milliliters, between control and intervention

  7. Effect on surgeon perceived difficulty [ Time Frame: Day of surgery ]
    Comparative surgeon perceived difficulty between control and intervention utilizing a surgeon and procedure specific survey



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients who are obese, BMI >30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery.
  • Patients between the ages of 18 and 65.
  • Patients scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

Exclusion Criteria:

  • Patients will be excluded from the study if they have any of the following:

    1. Recent myocardial infarction (3-6 months).
    2. History of cerebral vascular accident (stroke).
    3. Diabetes mellitus with a history of severe ketoacidosis.
    4. Patients on SGLT2 inhibitors (glifozins) without insulin
    5. Chronic use of steroids, greater than 20mg daily.
    6. Bleeding peptic ulcer (unless there is radiological evidence of healing 6 months prior to entry).
    7. A psychiatric history that includes suicide attempts and anyone taking psychotropic drugs, including lithium carbonate.
    8. Active thrombophlebitis (or any other condition where decreased blood volume would put the patient at risk).
  • In addition, patients who are pregnant are excluded. If status is unknown, a pregnancy test will be required prior to the start of the VLCD.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03553849


Contacts
Layout table for location contacts
Contact: Caitlin A Halbert, DO, MS 3023207175 caitlin.a.halbert@christianacare.org

Locations
Layout table for location information
United States, Delaware
Christiana Care Health System Recruiting
Newark, Delaware, United States, 19713
Contact: Caitlin A Halbert, DO, MS         
Sponsors and Collaborators
Christiana Care Health Services
Investigators
Layout table for investigator information
Principal Investigator: Caitlin A Halbert, DO, MS Christiana Care Health Services

Layout table for additonal information
Responsible Party: Christiana Care Health Services
ClinicalTrials.gov Identifier: NCT03553849     History of Changes
Other Study ID Numbers: 077069243
First Posted: June 12, 2018    Key Record Dates
Last Update Posted: July 15, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Christiana Care Health Services:
Very low calorie diet
General surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity, Morbid
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms